Avanir Pharmaceuticals
Aliso Viejo
About Avanir Pharmaceuticals
Avanir Pharmaceuticals is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of their commitment, they have extensively invested in their pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $46.2M
- Funding stage: M&A
- Last round: Post-IPO Debt (Jun 2012)
- Ticker: nasdaq:AVNR
- Website: avanir.com
- Phone: (194) 938-9670
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/avanir-pharmaceuticals-1421717 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.